“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: A-147 DIAGNOSTIC PERFORMANCE EVALUATION OF QUANTIA D-DIMER® REAGENT FOR PULMONARY EMBOLISM IN CLINICAL PRACTICE
A-147 DIAGNOSTIC PERFORMANCE EVALUATION OF QUANTIA D-DIMER® REAGENT FOR PULMONARY EMBOLISM IN CLINICAL PRACTICE
Reviews
There are no reviews yet.
Be the first to review “Article: A-147 DIAGNOSTIC PERFORMANCE EVALUATION OF QUANTIA D-DIMER® REAGENT FOR PULMONARY EMBOLISM IN CLINICAL PRACTICE” Cancel reply
Reviews
There are no reviews yet.